Note Agreements in the Biotechnology Industry

1,911 Contracts & Agreements

Browse by Company

AbbVie Inc. (8 contracts)
ABEONA THERAPEUTICS INC. (5)
ACADIA PHARMACEUTICALS INC (1)
ACCELERON PHARMA INC (1)
Acorda Therapeutics (5)
Adamas Pharmaceuticals Inc (2)
Adhera Therapeutics, Inc. (30)
ADiTx Therapeutics, Inc. (41)
ADMA BIOLOGICS, INC. (1)
ADURO BIOTECH, INC. (3)
Advaxis, Inc. (30)
AGENUS INC (11)
AgeX Therapeutics, Inc. (15)
Akebia Therapeutics, Inc. (5)
Alexion Pharmaceuticals (2)
Allarity Therapeutics, Inc. (10)
Alliqua BioMedical, Inc. (19)
Alpha Healthcare Acquisition Corp. (1)
Altimmune, Inc. (5)
Alzamend Neuro, Inc. (2)
AMARILLO BIOSCIENCES INC (15)
AMARIN CORP PLC (1)
Amgen Inc. (17)
AMICUS THERAPEUTICS, INC. (10)
AmpliPhi Biosciences Corp (1)
Amplitude Healthcare Acquisition Corp (1)
ANAVEX LIFE SCIENCES CORP. (7)
Aptevo Therapeutics Inc. (1)
AquaBounty Technologies, Inc. (2)
Aridis Pharmaceuticals, Inc. (4)
ARROWHEAD PHARMACEUTICALS, INC. (1)
Artiva Biotherapeutics, Inc. (1)
ARYA Sciences Acquisition Corp II (1)
ASSEMBLY BIOSCIENCES, INC. (4)
ATHERSYS, INC (1)
aTYR PHARMA INC (1)
Avid Bioservices, Inc. (3)
Axcella Health Inc. (1)
AZIYO BIOLOGICS, INC. (3)
AzurRx BioPharma, Inc. (4)
BeiGene, Ltd. (1)
BELLICUM PHARMACEUTICALS, INC (1)
Big Cypress Acquisition Corp. (1)
bioAffinity Technologies, Inc. (8)
BioAtla, Inc. (1)
BioCardia, Inc. (6)
BIOCEPT INC (10)
Biogen Inc. (3)
Biohaven Pharmaceutical Holding Co Ltd. (1)
BioLife4D Corp (18)
BIOMARIN PHARMACEUTICAL INC (6)
BioRestorative Therapies, Inc. (23)
Biostage, Inc. (2)
BIOTIME INC (4)
BioXcel Therapeutics, Inc. (1)
BIOXYTRAN, INC (16)
Bone Biologics Corp (24)
BullFrog AI Holdings, Inc. (2)
CALADRIUS BIOSCIENCES, INC. (3)
Calyxt, Inc. (2)
CANCER GENETICS, INC (12)
CAPRICOR THERAPEUTICS, INC. (3)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (7)
Capstone Therapeutics Corp. (11)
CareDx, Inc. (1)
Caribou Biosciences, Inc. (1)
CASI Pharmaceuticals, Inc. (8)
Castle Creek Biosciences, Inc. (1)
CATALYST BIOSCIENCES, INC. (4)
CATALYST PHARMACEUTICALS, INC. (1)
CEL SCI CORP (1)
Celcuity Inc. (1)
Cell Source, Inc. (29)
Celldex Therapeutics, Inc. (2)
Cellectar Biosciences, Inc. (2)
Celsion CORP (1)
Centessa Pharmaceuticals Ltd (3)
CEREBAIN BIOTECH CORP. (18)
Chanticleer Holdings, Inc. (5)
Chardan Healthcare Acquisition 2 Corp. (2)
Chardan Healthcare Acquisition Corp. (2)
Chelsea Worldwide Inc. (4)
CHIMERIX INC (1)
CLEVELAND BIOLABS INC (4)
CM Life Sciences III Inc. (1)
CohBar, Inc. (1)
Coherus BioSciences, Inc. (3)
Comera Life Sciences Holdings, Inc. (1)
Conatus Pharmaceuticals Inc. (3)
Consonance-HFW Acquisition Corp. (1)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (40)
CTD HOLDINGS INC (20)
CTI BIOPHARMA CORP (2)
Curative Biotechnology Inc (25)
CURIS INC (3)
Cyclacel Pharmaceuticals, Inc. (1)
CytoDyn Inc. (21)
CYTORI THERAPEUTICS, INC. (4)
DelMar Pharmaceuticals, Inc. (1)
Diffusion Pharmaceuticals Inc. (6)
Digital Development Partners, Inc. (14)
DYADIC INTERNATIONAL INC (5)
Dynamics Special Purpose Corp. (4)
Eidos Therapeutics, Inc. (1)
Emerald Bioscience, Inc. (2)
Emergent BioSolutions Inc. (4)
ENDONOVO THERAPEUTICS, INC. (9)
Enochian Biosciences Inc (9)
Entasis Therapeutics Holdings Inc. (1)
Environmental Impact Acquisition Corp (3)
Esperion Therapeutics, Inc. (1)
Exelixis (6)
FATE THERAPEUTICS INC (4)
FENNEC PHARMACEUTICALS INC. (1)
Fibrocell Science, Inc. (3)
FLUOROPHARMA MEDICAL, INC. (15)
Fortress Biotech, Inc. (6)
FS Development Corp. (1)
FS Development Corp. II (2)
GALECTIN THERAPEUTICS INC (5)
Gamida Cell Ltd. (1)
Gemphire Therapeutics Inc. (2)
Gene Biotherapeutics, Inc. (9)
GENELUX CORP (3)
GENEREX BIOTECHNOLOGY CORP (10)
Genprex, Inc. (3)
GeoVax Labs, Inc. (5)
GERON CORP (4)
Gilead Sciences (8)
Greater Cannabis Company, Inc. (15)
GT Biopharma, Inc. (27)
GX Acquisition Corp. (3)
HALOZYME THERAPEUTICS INC (2)
HARBOR DIVERSIFIED, INC. (2)
HCW Biologics Inc. (5)
Health Sciences Acquisitions Corp (1)
HEAT BIOLOGICS, INC. (10)
HedgePath Pharmaceuticals, Inc. (6)
HEMISPHERX BIOPHARMA INC (8)
HERON THERAPEUTICS, INC. (3)
HilleVax, Inc. (1)
Hillstream BioPharma Inc. (2)
HISTOGENICS CORP (5)
Homology Medicines, Inc. (2)
HUMANIGEN, INC (9)
iBio, Inc. (3)
IDERA PHARMACEUTICALS, INC. (2)
Immix Biopharma, Inc. (1)
IMMUCELL CORP (6)
IMMUNE PHARMACEUTICALS INC (13)
Immune Therapeutics, Inc. (30)
ImmunoCellular Therapeutics, Ltd. (1)
IMMUNOGEN INC (1)
IMPEL NEUROPHARMA INC (1)
Incyte (2)
INFINITY PHARMACEUTICALS, INC. (1)
Inhibikase Therapeutics, Inc. (6)
Inhibrx, Inc. (3)
Innovation Pharmaceuticals Inc. (1)
INOVIO PHARMACEUTICALS, INC. (1)
INSMED Inc (1)
Inspyr Therapeutics, Inc. (1)
INTERCEPT PHARMACEUTICALS, INC. (1)
International Stem Cell CORP (33)
INTREXON CORP (2)
Intrinsic Medicine, Inc. (1)
Invitae Corp (4)
IONIS PHARMACEUTICALS INC (2)
IOVANCE BIOTHERAPEUTICS, INC. (10)
IRONWOOD PHARMACEUTICALS INC (5)
Isoray, Inc. (2)
KalVista Pharmaceuticals, Inc. (2)
KBL MERGER CORP. IV (10)
Kiromic Biopharma, Inc. (29)
KIWA BIO-TECH PRODUCTS GROUP CORP (7)
Kodiak Sciences Inc. (4)
Kura Oncology, Inc. (4)
LA JOLLA PHARMACEUTICAL CO (1)
Leisure Acquisition Corp. (19)
LEXICON PHARMACEUTICALS, INC. (1)
LifeSci Acquisition Corp. (1)
Ligand Pharmaceuticals Incorporated (6)
Locust Walk Acquisition Corp. (2)
LONGEVERON LLC (1)
MADRIGAL PHARMACEUTICALS, INC. (4)
MANHATTAN SCIENTIFICS INC (5)
MANNKIND CORP (16)
MARIZYME INC (31)
Marker Therapeutics, Inc. (4)
MATEON THERAPEUTICS INC (22)
Medovex Corp. (19)
MiMedx Group, Inc. (7)
Minerva Neurosciences, Inc. (14)
MiNK Therapeutics, Inc. (5)
MIRAGEN THERAPEUTICS, INC. (2)
Molecular Templates, Inc. (1)
NANOVIRICIDES, INC. (2)
NantKwest, Inc. (22)
NAVIDEA BIOPHARMACEUTICALS, INC. (9)
NEWLINK GENETICS CORP (5)
NexImmune, Inc. (1)
NORTHWEST BIOTHERAPEUTICS INC (3)
NOVAVAX INC (10)
NTN BUZZTIME INC (9)
Nuo Therapeutics, Inc. (19)
Ohr Pharmaceutical Inc (2)
OncBioMune Pharmaceuticals, Inc (36)
OncoCyte Corp (1)
ONCOSEC MEDICAL Inc (1)
OPGEN INC (17)
Opko Health, Inc. (7)
ORAGENICS INC (23)
Organicell Regenerative Medicine, Inc. (3)
Organogenesis Holdings Inc. (4)
Orgenesis Inc. (14)
Outlook Therapeutics, Inc. (11)
PDL BIOPHARMA, INC. (3)
Petra Acquisition Inc. (5)
PharmaCyte Biotech, Inc. (1)
PIERIS PHARMACEUTICALS, INC. (2)
POLARITYTE, INC. (1)
PRECISION BIOSCIENCES INC (2)
PREDICTIVE TECHNOLOGY GROUP, INC. (1)
PREMIER BIOMEDICAL INC (25)
PROGENITY, INC. (5)
Propanc Biopharma, Inc. (113)
Protagenic Therapeutics, Inc. (20)
Protalix BioTherapeutics, Inc. (7)
PROTEOSTASIS THERAPEUTICS, INC. (1)
ProtoKinetix, Inc. (2)
PTC THERAPEUTICS, INC. (1)
PUMA BIOTECHNOLOGY, INC. (7)
Q BioMed Inc. (3)
Qrons Inc. (5)
Radius Health, Inc. (5)
Rasna Therapeutics Inc. (2)
Regeneron Pharmaceuticals (2)
REGENERX BIOPHARMACEUTICALS INC (14)
Regulus Therapeutics Inc. (1)
RenovaCare, Inc. (5)
RenovoRx, Inc. (3)
Retrophin, Inc. (4)
REXAHN PHARMACEUTICALS, INC. (4)
Rezolute, Inc. (3)
Rich Pharmaceuticals, Inc. (46)
RITTER PHARMACEUTICALS INC (7)
Sarepta Therapeutics, Inc. (1)
SELLAS Life Sciences Group, Inc. (6)
Shuttle Pharmaceuticals Holdings, Inc. (23)
Social Capital Suvretta Holdings Corp. III (2)
SOLENO THERAPEUTICS INC (7)
Sorrento Therapeutics, Inc. (7)
Spectrum Pharmaceuticals, Inc. (1)
SPHERIX INC (3)
Spinning Eagle Acquisition Corp. (1)
Stellar Biotechnologies, Inc. (1)
Summit Therapeutics Inc. (7)
Sun BioPharma, Inc. (10)
SUNESIS PHARMACEUTICALS INC (2)
Sunshine Biopharma, Inc (1)
Syndax Pharmaceuticals Inc (2)
Synthetic Biologics, Inc. (1)
TENAX THERAPEUTICS, INC. (4)
TG THERAPEUTICS, INC. (3)
Tonix Pharmaceuticals Holding Corp. (1)
Trovagene, Inc. (1)
U.S. Stem Cell, Inc. (8)
United Therapeutics Corp (1)
USA EQUITIES CORP. (6)
VACCINEX, INC. (1)
Verastem, Inc. (0)
Vertex Pharmaceuticals Inc (2)
Vicapsys Life Sciences, Inc. (1)
Viking Therapeutics, Inc. (1)
VistaGen Therapeutics, Inc. (12)
VITRO DIAGNOSTICS INC (15)
WINDTREE THERAPEUTICS INC (10)
Xenetic Biosciences, Inc. (5)
XOMA Corp (3)
YIELD10 BIOSCIENCE, INC. (4)

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

PROMISSORY NOTE

Note Agreements

Capstone Therapeutics Corp.

Biotechnology

2017

Convertible Promissory Note dated January 3, 2025 payable to Rafael Holdings, Inc

Note Agreements

CTD HOLDINGS INC

Biotechnology

2025

Seventh Amended and Restated Note Purchase Agreement dated as of January 3, 2025 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc

Note Agreements

CTD HOLDINGS INC

Biotechnology

2025

Second Amended and Restated Promissory Note Issued by Capstone Holding Corp. to Brookstone Partners Acquisition XXI Corporation, dated November 11, 2024

Note Agreements

Capstone Therapeutics Corp.

Biotechnology

2024

Term Note Issued by TotalStone, LLC, Northeast Masonry Distributors, LLC, and TotalStone Properties, LLC to Berkshire Bank, dated November 22, 2021

Note Agreements

Capstone Therapeutics Corp.

Biotechnology

2024

Second Amended and Restated Promissory Note, dated November 11, 2024, issued by Capstone Holding Corp. to BP Peptides, LLC

Note Agreements

Capstone Therapeutics Corp.

Biotechnology

2024

Non-negotiable Secured Subordinated Contingent Value Promissory Note by and between NEM Purchaser, LLC and Northeast Masonry Distributors, LLC

Note Agreements

Capstone Therapeutics Corp.

Biotechnology

2024

Non-negotiable Secured Subordinated Promissory Note by and between TotalStone, LLC and Northeast Masonry Distributors, LLC

Note Agreements

Capstone Therapeutics Corp.

Biotechnology

2024

Amendment to Convertible Promissory Notes dated as of December 21, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc

Note Agreements

CTD HOLDINGS INC

Biotechnology

2024

Note Purchase Agreement, dated December 17, 2024, by and among Clene Inc., Kensington Clene 2024 LLC, 4Life Research, LLC and La Scala Investments, LLC

Note Agreements

Chelsea Worldwide Inc.

Biotechnology

2024

Convertible Promissory Note dated December 4, 2024

Note Agreements

Propanc Biopharma, Inc.

Biotechnology

2024

Convertible Promissory Note dated December 15, 2024

Note Agreements

Propanc Biopharma, Inc.

Biotechnology

2024

Form of the 25% Senior Secured Convertible Promissory Note

Note Agreements

Kiromic Biopharma, Inc.

2024

Second Amended and Restated Promissory Note by and between the Company and Nant Capital, LLC, dated as of December 10, 2024

Note Agreements

NantKwest, Inc.

2024

Form of Senior Secured Convertible Note

Note Agreements

HEAT BIOLOGICS, INC.

2024

Convertible Promissory Note dated December 5, 2024 payable to Rafael Holdings, Inc

Note Agreements

CTD HOLDINGS INC

2024

Sixth Amended and Restated Note Purchase Agreement dated as of December 5, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc

Note Agreements

CTD HOLDINGS INC

2024

Form of Promissory Note

Note Agreements

HEAT BIOLOGICS, INC.

2024

Form of Unsecured Bridge Note

Note Agreements

GX Acquisition Corp.

2024

Senior Convertible Promissory Tranche B Note issued to Nant Capital, LLC, dated November 15, 2024

Note Agreements

Sun BioPharma, Inc.

2024

Form of First Amendment to the Amended and Restated Senior Secured Note Purchase Agreement, dated September 30, 2024, by and between the Company and Purchaser parties thereto

Note Agreements

HCW Biologics Inc.

2024

Subordinated Promissory Note, dated as of August 19, 2024

Note Agreements

Sun BioPharma, Inc.

2024

Amendment No. 1 to the Secured Promissory Note between the Company and Nuseed Nutritional US Inc. dated November 7, 2024

Note Agreements

YIELD10 BIOSCIENCE, INC.

2024

Secured Promissory Note between the Company and Nuseed Nutritional US Inc. dated September 5, 2024

Note Agreements

YIELD10 BIOSCIENCE, INC.

2024

Convertible Promissory Note dated November 7, 2024 payable to Rafael Holdings, Inc

Note Agreements

CTD HOLDINGS INC

2024

Fifth Amended and Restated Note Purchase Agreement dated as of November 7, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc

Note Agreements

CTD HOLDINGS INC

2024

Promissory Note, dated as of November 4, 2024, by and between Orgenesis Maryland LLC, the Company and Jacob Safier

Note Agreements

Orgenesis Inc.

2024

Senior Convertible Promissory Tranche A Note issued to Nant Capital, LLC, dated October 22, 2024

Note Agreements

Sun BioPharma, Inc.

2024

Note Purchase Agreement, dated October 22, 2024, between Nant Capital, LLC, as Investor, and Panbela Therapeutics, Inc., as Company

Note Agreements

Sun BioPharma, Inc.

2024

Clinical Trial Funding Agreement, by and among Double Point Ventures LLC and Lumos Pharma, Inc., dated October 22, 2024 (including the form of Note with respect thereto)

Note Agreements

NEWLINK GENETICS CORP

2024

Form of Senior Secured Convertible Notes

Note Agreements

Shuttle Pharmaceuticals Holdings, Inc.

2024

Amendment to Convertible Promissory Notes dated as of October 8, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc

Note Agreements

CTD HOLDINGS INC

2024

Convertible Promissory Note dated October 8, 2024 payable to Rafael Holdings, Inc

Note Agreements

CTD HOLDINGS INC

2024

Fourth Amended and Restated Note Purchase Agreement dated as of October 8, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc

Note Agreements

CTD HOLDINGS INC

2024

Amendment to Form of Senior Secured Convertible Promissory Note due March 8, 2027

Note Agreements

DYADIC INTERNATIONAL INC

2024

Convertible Promissory Note dated September 20, 2024

Note Agreements

Propanc Biopharma, Inc.

2024

Form of 12.0% senior convertible note issued under the note purchase agreement, dated as of September 24, 2024, between Eterna Therapeutics Inc. and the purchaser parties thereto

Note Agreements

NTN BUZZTIME INC

2024

Note purchase agreement, dated as of September 24, 2024, between Eterna Therapeutics Inc. and the purchaser parties thereto

Note Agreements

NTN BUZZTIME INC

2024

Form of Senior Note (September 2024)

Note Agreements

ADiTx Therapeutics, Inc.

2024

Form of Note issued on September 15, 2024

Note Agreements

International Stem Cell CORP

2024

Form of Promissory Note, dated September 4, 2024, between Shuttle Pharmaceuticals and Anatoly Dritschilo

Note Agreements

Shuttle Pharmaceuticals Holdings, Inc.

2024